Status:
UNKNOWN
Effect of CPAP in the Worsening of Renal Function in Early Stages of Chronic Kidney Disease (CKD)
Lead Sponsor:
Sociedad Española de Neumología y Cirugía Torácica
Conditions:
Chronic Kidney Insufficiency
Sleep Apnea
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Objectives: Evaluate the effect of CPAP to reduce the progression of chronic kidney disease or CKD (the decline of glomerular filtration rate is ≥ 30%) in patients with early-stage renal disease and s...
Detailed Description
There is a bidirectional involvement between the chronic kidney disease (CKD) and sleep apnea syndrome (OSAS). The declining of renal function, the fluid overloading and the disturbance of ventilation...
Eligibility Criteria
Inclusion
- Patients referred to the outpatient nephrology department with a diagnosis of chronic kidney disease stages G1-3 KDIGO
- Older than18 years
- Habitual snoring or observed apneas
- Scale sleep sleepiness (Epworth Test) with 11 points or lower.
Exclusion
- Very debilitating chronic or neoplastic disease
- Respiratory failure (PaO 2 \<55 mm Hg).
- Other symptoms of suspected sleep disorder different from OSAS.
- Patients unable to perform self-administered questionnaires.
- Patients with\> 50% of central apnea or Cheyne-Stokes.
- Patients who do not sign the informed consent.
Key Trial Info
Start Date :
November 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 20 2020
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT03319888
Start Date
November 20 2017
End Date
May 20 2020
Last Update
March 6 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jaime Corral
Cáceres, Spain, 10003